TY - JOUR
T1 - The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities
AU - Marchaim, Dror
AU - Chopra, Teena
AU - Bogan, Christopher
AU - Bheemreddy, Suchitha
AU - Sengstock, David
AU - Jagarlamudi, Rajasekhar
AU - Malani, Anurag
AU - Lemanek, Leslie
AU - Moshos, Judy
AU - Lephart, Paul R.
AU - Ku, Kimberley
AU - Hasan, Asma
AU - Lee, Jiha
AU - Khandker, Namir
AU - Blunden, Christopher
AU - Geffert, Sara F.
AU - Moody, Megan
AU - Hiro, Rahbar
AU - Wang, Yujing
AU - Ahmad, Farah
AU - Mohammadi, Tarana
AU - Faruque, Omar
AU - Patel, Diixa
AU - Pogue, Jason M.
AU - Hayakawa, Kayoko
AU - Dhar, Sorabh
AU - Kaye, Keith S.
PY - 2012/10
Y1 - 2012/10
N2 - Background: Long-term acute care (LTAC) facilities admit patients with complex, advanced disease states. Study aims were to determine the burden posed on hospitals associated with LTAC exposure and analyze the differences between "present on admission" (POA) multidrug-resistant (MDR), gram-negative organisms (GNO) and POA MDR gram-positive organisms (GPO). Methods: A multicenter retrospective study was conducted in 13 hospitals from southeast Michigan, from September 1, 2008, to August 31, 2009. Cultures obtained in the first 72 hours of hospitalization (ie, POA) of MDR-GPO and MDR-GNO were reviewed. LTAC exposures in the previous 6 months and direct admission from a LTAC were recorded. Results: Overall, 5,297 patients with 7,147 MDR POA cultures were analyzed: 2,619 (36.6%) were MDR-GNO, and 4,528 (63.4%) were MDR-GPO. LTAC exposure in the past 6 months was present in 251 (5.2%) infectious episodes and was significantly more common among POA MDR-GNO than MDR-GPO (158 [8.6%] and 94 [3.1%], respectively, odds ratio, 2.87; P <.001). Recent LTAC exposure was strongly associated with both carbapenem-resistant Enterobacteriaceae (CRE) (31.6% of all CRE cases, P <.001) and Acinetobacter baumannii (14.9% of all A baumannii cases, P <.001). Conclusion: Nearly 10% of MDR-GNO POA had recent LTAC exposure. Hospital efforts to control the spread of MDR-GNO should focus on collaborations and communications with referring LTACs and interventions targeted towards patients with recent LTAC exposure.
AB - Background: Long-term acute care (LTAC) facilities admit patients with complex, advanced disease states. Study aims were to determine the burden posed on hospitals associated with LTAC exposure and analyze the differences between "present on admission" (POA) multidrug-resistant (MDR), gram-negative organisms (GNO) and POA MDR gram-positive organisms (GPO). Methods: A multicenter retrospective study was conducted in 13 hospitals from southeast Michigan, from September 1, 2008, to August 31, 2009. Cultures obtained in the first 72 hours of hospitalization (ie, POA) of MDR-GPO and MDR-GNO were reviewed. LTAC exposures in the previous 6 months and direct admission from a LTAC were recorded. Results: Overall, 5,297 patients with 7,147 MDR POA cultures were analyzed: 2,619 (36.6%) were MDR-GNO, and 4,528 (63.4%) were MDR-GPO. LTAC exposure in the past 6 months was present in 251 (5.2%) infectious episodes and was significantly more common among POA MDR-GNO than MDR-GPO (158 [8.6%] and 94 [3.1%], respectively, odds ratio, 2.87; P <.001). Recent LTAC exposure was strongly associated with both carbapenem-resistant Enterobacteriaceae (CRE) (31.6% of all CRE cases, P <.001) and Acinetobacter baumannii (14.9% of all A baumannii cases, P <.001). Conclusion: Nearly 10% of MDR-GNO POA had recent LTAC exposure. Hospital efforts to control the spread of MDR-GNO should focus on collaborations and communications with referring LTACs and interventions targeted towards patients with recent LTAC exposure.
KW - Acinetobacter baumannii
KW - Antimicrobial resistance
KW - CRE
KW - Infection control
KW - Infections upon admission
KW - LTAC
KW - MDR
UR - http://www.scopus.com/inward/record.url?scp=84863647825&partnerID=8YFLogxK
U2 - 10.1016/j.ajic.2011.09.011
DO - 10.1016/j.ajic.2011.09.011
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 22285709
AN - SCOPUS:84863647825
SN - 0196-6553
VL - 40
SP - 760
EP - 765
JO - American Journal of Infection Control
JF - American Journal of Infection Control
IS - 8
ER -